Ozempic Side Effects: From the First-Week Nausea to the Question Everyone Asks About Hair

What are the most common Ozempic side effects?

Semaglutide slows how quickly your stomach empties and turns down appetite signals in the brain, and most of what people feel in the first weeks traces back to that one mechanism. Nausea is by far the most frequently reported complaint in the clinical trials that led to Ozempic's approval, affecting roughly one in five patients at some point during treatment. Vomiting is less common. Diarrhea and constipation round out the list, sometimes alternating in the same person over a few weeks.

• Nausea — most common, usually strongest in the first weeks and after each dose increase
• Vomiting — less common than nausea, more likely early in treatment
• Diarrhea and constipation — sometimes both, at different points
• Abdominal pain or bloating
• Fatigue or mild dizziness, particularly if food intake drops sharply
• Injection-site redness or irritation

None of this is a sign of anything gone wrong. It's the expected pharmacology of the drug doing its job, and it's the reason Ozempic's dosing schedule increases slowly rather than starting at a maintenance dose.

Is Ozempic actually safe for weight loss?

Here's the detail that trips people up: Ozempic is FDA-approved for type 2 diabetes, full stop. Wegovy — a higher-dose version of the same semaglutide molecule — carries the FDA's chronic weight-management approval. When someone asks whether Ozempic is safe for weight loss, they're almost always describing off-label use: a provider prescribing Ozempic specifically to help a patient lose weight, without a diabetes diagnosis.

Off-label doesn't mean untested. It's the same active ingredient studied at similar doses in Wegovy's own weight-management trials, and the side-effect profile carries over. What doesn't carry over automatically is insurance coverage — plans that pay for Ozempic under a T2D diagnosis routinely deny it when the stated reason is weight loss — and the fact that a provider prescribing off-label is working outside the specific population the FDA reviewed for that exact use case. For most healthy adults without diabetes, that's a coverage and cost question more than a safety one, but it's worth naming honestly rather than assuming the FDA label covers a use it doesn't.

Do Ozempic side effects include hair loss?

There's no established mechanism by which semaglutide acts on hair follicles directly. What does happen, in some people, is telogen effluvium — a temporary, diffuse shedding pattern that follows any sufficiently fast weight loss, whatever caused it. Losing weight quickly pushes a larger share of hair follicles out of their growth phase and into a resting phase at the same time, and a few months later, that resting hair sheds all together instead of gradually. Reduced calorie and protein intake during rapid weight loss is thought to be a contributing factor as well.

The timing is fairly consistent: shedding tends to start a few months after the weight loss itself, not immediately after starting the medication, which is part of why people are often surprised by it. It's also self-limiting for most people — once weight stabilizes and intake normalizes, hair density typically recovers over the following several months. In Wegovy's own weight-management trials (same molecule, higher dose), hair loss was reported by a small minority of participants, versus a smaller share on placebo — consistent with a rapid-weight-loss effect rather than a direct drug effect. If you're already noticing perimenopausal thinning, that same telogen-effluvium mechanism is worth understanding on its own terms — see perimenopause hair loss for the fuller picture of what else can be driving it and what actually helps.

What are the bad, serious side effects of Ozempic?

A separate, shorter list sits below the common complaints — less frequent, but the reason Ozempic carries the warnings it does.

• Pancreatitis — inflammation of the pancreas, uncommon but documented in GLP-1 receptor agonist trials and postmarketing reports; people with a personal history of pancreatitis are typically advised against this class of drug
• Gallbladder disease — gallstones (cholelithiasis) were reported at a meaningfully higher rate in Ozempic's own trials than with placebo, most likely tied to the rapid weight loss itself rather than a direct drug toxicity
• Thyroid C-cell tumors — Ozempic carries a boxed warning based on rodent studies, where semaglutide caused thyroid C-cell tumors at clinically relevant exposures; whether this applies to humans hasn't been established, and no confirmed case has been reported in humans, but the drug is contraindicated for anyone with a personal or family history of medullary thyroid carcinoma or MEN 2
• Hypoglycemia — the risk rises meaningfully when Ozempic is combined with insulin or a sulfonylurea; the FDA label documents symptomatic low blood sugar in roughly one in six to one in four patients on that combination, which is why a prescriber typically lowers the other medication's dose first
• Diabetic retinopathy complications — in the SUSTAIN-6 cardiovascular trial, retinopathy complications occurred somewhat more often with semaglutide than placebo, concentrated almost entirely in patients who already had retinopathy at baseline; this is specific to people with type 2 diabetes and an existing eye condition
• Kidney injury — most reported cases trace back to dehydration from vomiting or diarrhea rather than a direct effect on the kidney, which is why staying ahead of fluid losses during a rough GI stretch matters more than it might seem

Which side effects need same-day medical attention?

The everyday nausea-and-bloating cluster above is one category. This is a different one — specific symptoms that overlap with the serious risks and shouldn't wait for a routine follow-up message.

• Severe, persistent abdominal pain, especially if it radiates to your back, with or without vomiting — a possible sign of pancreatitis
• Pain in the upper right abdomen, fever, or yellowing of the skin or eyes — possible gallbladder involvement
• A new lump or swelling in your neck, persistent hoarseness, or trouble swallowing — the symptoms the FDA specifically asks prescribers to counsel patients on given the thyroid warning
• Sudden vision changes or vision loss, particularly if you have type 2 diabetes with a retinopathy history
• Signs of severe dehydration — very reduced urination, dizziness on standing, confusion — especially after several days of vomiting or diarrhea
• Signs of severe low blood sugar if you also take insulin or a sulfonylurea — shakiness, confusion, sweating that doesn't resolve with food

One more area worth addressing directly, since it circulated widely: after postmarketing reports raised the question starting in 2023, the FDA ran a comprehensive review of clinical trial and safety data across the GLP-1 class. The agency's own conclusion, published in early 2026, found no increased risk of suicidal ideation or behavior associated with these medications, and the FDA has asked manufacturers to remove that warning language from GLP-1 labeling. That said, any new or worsening low mood, hopelessness, or thoughts of self-harm is worth reaching out about immediately — not because this drug class has been shown to cause it, but because that symptom deserves the same response regardless of what's on a label.

What about the long-term side effects of Ozempic — what's still being studied?

Ozempic has been prescribed for type 2 diabetes since 2017, which means there's substantial long-term safety data for that original population. What's newer is the scale of off-label weight-loss use, often at doses and durations outside what the original diabetes trials studied most closely. A few questions are still being actively worked through in the research: how sustained rapid weight loss over several years affects bone density and muscle mass, whether the thyroid signal seen in rodents holds any relevance in long-term human use as more years of exposure accumulate, and what happens metabolically for people who eventually stop the medication after using it for weight management rather than diabetes control. None of that is a reason to assume a hidden danger — it's simply the honest state of a drug whose off-label use case is younger than its original one.

Does Ozempic cause muscle loss?

Yes, to some degree — a meaningful share of the weight lost on any GLP-1 medication is lean mass rather than fat, and that's a pattern seen across the drug class in weight-management trials, not something unique to semaglutide. It matters more after 40, when perimenopause is already eroding muscle on its own. For the specific research behind that finding and what actually protects muscle during GLP-1 weight loss, see GLP-1s and muscle loss in perimenopause.

Are Ozempic side effects different in men?

The core profile — nausea, GI symptoms, gallbladder and pancreatitis risk — doesn't differ meaningfully by sex in the trial data Ozempic's label is built on. The area that's genuinely still being sorted out is sexual and hormonal health: some retrospective research has raised questions about erectile function and testosterone levels in men using semaglutide, while separately, weight loss itself tends to raise testosterone in men who started out with obesity, which points the opposite direction. The research here is early and the findings are mixed enough that no firm, sex-specific side-effect profile is established yet — worth discussing with a provider if it's a personal concern rather than treating either direction as settled.

How do you manage the common side effects?

A handful of practical habits cover most of what shows up in the first weeks.

• Respect the titration schedule — dose increases are spaced roughly a month apart specifically to give your gut time to adjust; asking to move faster tends to backfire
• Go smaller and lower-fat with meals — semaglutide already slows digestion, and a large or fatty meal on top of that is the most common trigger for nausea
• Stay ahead of hydration, especially during a rough stretch of vomiting or diarrhea — this is the single biggest lever against the dehydration-driven kidney concern above
• Track timing — some people do better injecting at a specific time of day or day of the week once they notice when nausea tends to peak

Where to get help if a side effect isn't settling

If a symptom is dragging past the first few months, or you want labs to confirm what's going on rather than guessing, the differences between providers show up less in the sticker price and more in what's included once you're already enrolled.

PlushCare leans on insurance rather than a flat membership, which is worth considering if a side effect means you'll need more than one follow-up visit — an in-network copay adds up to far less than repeat cash visits elsewhere. Ro takes the opposite approach: a $145/mo membership that already includes labs, so if a symptom needs bloodwork to sort out, that's built into what you're already paying rather than a new charge.

Mochi Health and Henry Meds both compound semaglutide rather than dispensing the branded pen — a non-FDA-approved product made by a licensed pharmacy rather than Novo Nordisk, worth knowing before you enroll. Both charge a monthly rate that doesn't rise with your dose, though Henry Meds' pricing pages describe both flat and prepay-tier structures, so confirm which applies before enrolling if a possible side effect might mean canceling early.